About the job
Who We Are:
Cogent Biosciences is a publicly traded biotechnology firm dedicated to pioneering innovative precision therapies aimed at addressing diverse patient needs in the medical field. Our flagship program, bezuclastinib, is engineered to selectively and effectively inhibit exon 17 mutations present in the KIT receptor tyrosine kinase, notably including KIT D816V. This mutation is a primary driver of Systemic Mastocytosis, a rare and serious disease, while exon 17 mutations are also implicated in gastrointestinal stromal tumors (GIST), a cancer type reliant on aberrant KIT signaling. Bezuclastinib has demonstrated promising outcomes in early trials: APEX in AdvSM, SUMMIT in NonAdvSM, and PEAK in GIST, showcasing a favorable safety profile across more than 600 patients in both standalone and combination therapies.
Position Overview:
- The National Account Director (NAD) is tasked with securing profitable coverage access with national payer organizations, including GPOs, PBMs, and major regional account clients.
- This role is pivotal in executing our Market Access objectives and strategies directed at the payer audience.
- The NAD will collaborate with various internal teams such as Market Access, Marketing, Commercial Operations, Sales, and Medical to align strategies with our key clients, ensuring optimal experiences for both patients and providers.
Key Responsibilities:
- Implement tailored customer strategies that align with our overall product and business objectives.
- Communicate the value of our offerings by managing relationships with all customer stakeholders.
- Design and execute corporate strategies tailored to the market access payer landscape, maximizing Cogent's access and profitability.
- Lead discussions with key strategic accounts, including clinical and contracting negotiations as necessary.
- Stay informed on developments among government and private insurers to inform Market Access strategies, enabling proactive responses to market changes.
- Establish, nurture, and expand relationships with senior executives at key accounts.
